Main Session
Sep
30
QP 37 - From Detection to Re-treatment: Managing Radiorecurrent Prostate Cancer
1221 - MRI-Guided Risk-Adaptive High Dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: A Phase II Trial
Presenter(s)
Bryce Thomsen, MD - Brigham and Women's Hospital/Dana Farber Cancer Institute, Boston, MA